Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck's New Drugs Are Bringing New Hope
Seeking Alpha
Thursday, February 6, 2014 - 11:59am
tags:
Merck, Januvia, China, India, MK-3475
Circassia Plans $285 Million IPO to Fund Allergy Vaccines
Bloomberg
Thursday, February 6, 2014 - 10:18am
tags:
Circassia, IPOs, vaccines, allergies
AstraZeneca takes on Merck in Alzheimer's drug race
Yahoo/Reuters
Thursday, February 6, 2014 - 9:57am
tags:
AstraZeneca, Merck, Alzheimer's disease, AZD3293, BACE inhibitors
Revance Therapeutics IPO May Make You Look Good
Seeking Alpha
Thursday, February 6, 2014 - 9:54am
tags:
ReVance, IPOs
Smith & Nephew positive after strong finish to 2013
Reuters
Thursday, February 6, 2014 - 8:47am
tags:
devices, Smith & Nephew, earnings
Device makers skeptical of Google's glucose sensing contact lenses
Mass Device
Thursday, February 6, 2014 - 8:47am
tags:
devices, blood glucose monitoring, Google X
AstraZeneca quietly sweeps out some notable mid-stage drug programs
Fierce Biotech
Thursday, February 6, 2014 - 8:38am
tags:
AstraZeneca, MEDI-5117, AZD8330, AZD6765, MEDI-557, MEDI-575, AZD5423, AZD7594, AZD1446, AZD3480, AZD5213
AstraZeneca steps up its global restructuring with 550 new job cuts
Fierce Pharma
Thursday, February 6, 2014 - 8:35am
tags:
layoffs, AstraZeneca
AbbVie Expands Manufacturing Presence with US$320 Million Investment in Singapore
Yahoo
Thursday, February 6, 2014 - 7:50am
tags:
AbbVie, Singapore, drug manufacturing
St. Jude Medical announces first U.S. patient implant of non-surgical pacemaker
Yahoo/Fly on the Wall
Thursday, February 6, 2014 - 7:49am
tags:
St. Jude Medical, non-surgical pacemaker, devices, Nanostim
The Dream Of The Insulin Pill: Oramed Vs. Rivals
Seeking Alpha
Thursday, February 6, 2014 - 7:47am
tags:
insulin, diabetes, Oramed, oral insulin, ORMD-0801, NN1954, Novo Nordisk
Teva Pharm Q4 profit, revenue top estimates
Yahoo/Reuters
Thursday, February 6, 2014 - 7:45am
tags:
earnings, Teva Pharmaceuticals
Repros Meets With FDA to Discuss Data Requirements for Androxal(R) in the Treatment of Secondary Hypogonadism
Yahoo
Thursday, February 6, 2014 - 7:44am
tags:
Repros, FDA, Androxal, secondary hypogonadism
Gilead Sciences, Inc Has a Potential Blockbuster Drug for 2014
Motley Fool
Thursday, February 6, 2014 - 7:43am
tags:
Gilead Sciences, hepatitis C, Sovaldi
Here's Why Palbociclib is Helping Pfizer Avoid the Sell-Off
Motley Fool
Thursday, February 6, 2014 - 6:53am
tags:
palbociclib, Pfizer, breast cancer
Big Pharma pushes for U.S. action against India over patent worries
Yahoo/Reuters
Thursday, February 6, 2014 - 6:52am
tags:
India, patents, Pfizer, Roche, Sanofi, Novartis
AstraZeneca profits heading south as patent losses bite
Yahoo/Reuters
Thursday, February 6, 2014 - 6:51am
tags:
AstraZeneca, earnings, patents
Sanofi Sees Profit Gain, Cautious Forecast Disappoints
Bloomberg
Thursday, February 6, 2014 - 6:50am
tags:
earnings, Sanofi, M&A
AbbVie Inc. Is Closer to Much-Needed Diversification, but Is It Enough?
Motley Fool
Wednesday, February 5, 2014 - 7:00pm
tags:
AbbVie, earnings
Gilead to license hepatitis C drug to lower-cost manufacturers in India
Yahoo/Reuters
Wednesday, February 5, 2014 - 6:57pm
tags:
hepatitis C, India, Gilead Sciences, Sovaldi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.